combretastatin: Clinical Trials

2 trials of combretastatin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 terminated. 2 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 22Completed 1, Terminated 1
Phase 31Terminated 1

Follow combretastatin: new trials by email Literature Review of combretastatin trials Research Report on combretastatin

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study Evaluating the Safety and Response of Fosbretabulin in Asian Patients With Polypoidal Choroidal Vasculopathy (PCV)
fosbretabulin, Saline - Polypoidal Choroidal Vasculopathy
Phase 2CompletedMateon Therapeutics202009-07-012011-11-01
Study of Combretastatin and Paclitaxel/Carboplatin in the Treatment of Anaplastic Thyroid Cancer
CA4P, paclitaxel, carboplatin - Anaplastic Thyroid Cancer
Phase 2 / Phase 3TerminatedMateon Therapeutics802007-08-012014-06-09

Conditions studied

Polypoidal Choroidal Vasculopathy (1)  ·  Thyroid Carcinoma, Anaplastic (1)  ·  Thyroid Neoplasms (1)

Sponsors

Mateon Therapeutics (2)

Countries

United States (2)  ·  Belarus (1)  ·  Bulgaria (1)  ·  Egypt (1)  ·  Hong Kong (1)  ·  India (1)  ·  Israel (1)  ·  Italy (1)  ·  Poland (1)  ·  Romania (1)  ·  Russia (1)  ·  Singapore (1)  ·  South Korea (1)  ·  Taiwan (1)  ·  Ukraine (1)

Top investigators

Julie A. Sosa, MD, FACS (1)

Results publications

PMID 37816266